Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Sales | 0 | 0 | 0 | 0 | 210 |
| Gross Profit | N/A | N/A | N/A | N/A | 210 |
| Operating Expenses | 3,467 | 3,609 | 3,051 | 2,844 | 2,770 |
| Operating Income | -3,467 | -3,609 | -3,051 | -2,844 | -2,560 |
| Other Income | 287 | 319 | 330 | 296 | 253 |
| Pre-tax Income | -3,180 | -3,290 | -2,721 | -2,548 | -2,307 |
| Net Income Continuous | -3,180 | -3,290 | -2,721 | -2,548 | -2,307 |
| Minority Interests | -41 | -35 | -31 | -37 | -19 |
| Net Income | $-3,139 | $-3,255 | $-2,690 | $-2,511 | $-2,288 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.09 | -0.08 | -0.07 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.09 | -0.08 | -0.07 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.09 | -0.08 | -0.07 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.09 | -0.08 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.10 | -0.09 | -0.08 | -0.07 |
| EBITDA(a) | $-3,455 | $-3,596 | $-3,039 | $-2,833 | $-2,548 |